As the Biden Administration begins to implement its agenda, and with the 117th Congress now fully controlled by Democrats, the pace of activity in Washington is poised to accelerate. In this post, we have detailed a cross section of the Biden Administration’s domestic priorities, provided analysis of them, and offered a strategic overview of how companies can position themselves to simultaneously benefit from this activity and, importantly, prepare in the event they become the focus of unwanted scrutiny.
Posts by Michael Robinson
Michael R. Robinson is a consultant for Westwicke and ICR.
Clinical trial data disclosure can be tricky.
Download our checklist of 10 disclosure guidelines to minimize risk and maximize the impact of good news.